Vascular Solutions Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Vascular Solutions (VASC) '3-for-3' in 2015; Canaccord Genuity Reiterates Buy
October 21, 2015 11:07 AM EDTCanaccord Genuity reiterated a Buy rating and $41.50 price target on Vascular Solutions (NASDAQ: VASC), following the company's 3Q15 earnings results. VASC reported its 3rd straight quarter beat and raise in 2015, beating consensus' EPS by $0.02.
Analyst Jason Mills commented, "In terms of a beat and raise batting average,... More
Vascular Solutions (VASC) Tops Q3 EPS by 2c; Boosts FY15 Outlook
October 20, 2015 4:07 PM EDTVascular Solutions (NASDAQ: VASC) reported Q3 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $37 million versus the consensus estimate of $36.41 million.
Vascular Solutions sees FY2015 EPS of $1.03-$1.05, versus the consensus of $1.03. Vascular Solutions sees FY2015... More
